Eberle R, Hilliard J K
Department of Veterinary Parasitology, Microbiology and Public Health, College of Veterinary Medicine, Oklahoma State University, Stillwater 74078.
J Clin Microbiol. 1989 Jun;27(6):1357-66. doi: 10.1128/jcm.27.6.1357-1366.1989.
Sera from captive lowland gorillas, chimpanzees, orangutans, and gibbons were screened by enzyme-linked immunosorbent assay (ELISA) for antibody to herpesviruses serologically related to human herpes simplex virus types 1 and 2 (HSV-1, HSV-2), a baboon virus (SA8), and a macaque herpesvirus (B virus). The incidence of herpesvirus antibodies varied considerably among the different species, gorillas having the highest incidence of seropositivity (65.4%) and orangutans the lowest. The virus specificity of positive sera was further analyzed by examining the kinetics of virus neutralization, competition of reactivity in ELISAs, and immunoblotting against HSV-1, HSV-2, SA8, and B virus antigens. Using these assays, the majority of positive gorilla sera (49 of 53, 92%) were determined to react in a manner identical to human HSV-1 immune sera. The remaining four positive gorilla sera reacted as HSV-2-positive sera. In contrast, the majority of positive chimpanzee sera (5 of 7, 71%) reacted as HSV-2 immune rather than HSV-1 immune. All positive sera from gibbon apes reacted as HSV-1 positive. No orangutan sera were identified which gave positive reactions by ELISAs to any of the four primate herpesviruses tested. Although four orangutan sera gave equivocal results against HSV-1 antigen, further analysis by immunoblotting could not confirm any specific reactivity with any of the primate herpesvirus antigens. Varied reactivity among individual animals with both SA8 and B virus proteins was observed, but none of the seropositive primates detected appeared to be infected with either of these simian viruses. Three gorilla sera had antigen recognition patterns slightly different from those of HSV-2-positive human and chimpanzee sera and another HSV-2-positive gorilla serum, raising the possibility that these animals harbor an indigenous virus related to HSV-2.
采用酶联免疫吸附测定(ELISA)对圈养的低地大猩猩、黑猩猩、猩猩和长臂猿的血清进行筛查,以检测其针对与人类单纯疱疹病毒1型和2型(HSV - 1、HSV - 2)、一种狒狒病毒(SA8)以及一种猕猴疱疹病毒(B病毒)血清学相关的疱疹病毒的抗体。疱疹病毒抗体的发生率在不同物种间差异很大,大猩猩的血清阳性率最高(65.4%),猩猩的最低。通过检测病毒中和动力学、ELISA中反应性的竞争以及针对HSV - 1、HSV - 2、SA8和B病毒抗原的免疫印迹,进一步分析阳性血清的病毒特异性。使用这些检测方法,大多数阳性大猩猩血清(53份中的49份,92%)被确定以与人类HSV - 1免疫血清相同的方式反应。其余4份阳性大猩猩血清的反应与HSV - 2阳性血清相同。相比之下,大多数阳性黑猩猩血清(7份中的5份,71%)的反应为HSV - 2免疫而非HSV - 1免疫。来自长臂猿的所有阳性血清反应均为HSV - 1阳性。未鉴定出对所检测的四种灵长类疱疹病毒中的任何一种通过ELISA产生阳性反应的猩猩血清。尽管四份猩猩血清针对HSV - 1抗原给出了模糊结果,但通过免疫印迹进一步分析无法确认与任何灵长类疱疹病毒抗原的任何特异性反应性。观察到个体动物对SA8和B病毒蛋白的反应性各不相同,但检测到的血清阳性灵长类动物似乎均未感染这两种猿猴病毒中的任何一种。三份大猩猩血清的抗原识别模式与HSV - 2阳性的人类和黑猩猩血清以及另一份HSV - 2阳性大猩猩血清略有不同,这增加了这些动物携带与HSV - 2相关的本土病毒的可能性。